CELL BIOTECH CO ., LTD

049960 KRX Pharmaceuticals Pharmaceuticals
KOSDAQ
₩15,300.00
+0.20%
Delayed · cached 15 min

Fair value analysis

049960
CELL BIOTECH CO ., LTD
Pharmaceuticals›Pharmaceuticals
₩15,300.00
Close used for this calculation
₩21,123.16Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
75/100
Profitability17/25
Returns8/25
Balance Sheet25/25
Efficiency25/25
Growth16/25
Strong
Quality radar
75Prof.17/25Ret.8/25Eff.25/25B.Sht25/25Growth16/25

Consensus fair value

₩21,123.16
Below FV
▲ +38.1% against the close used
Model range ₩8,533.83 – ₩39,518.88
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩8,533.83Fair value₩21,123.16Bull₩39,518.88
FairClose
52-week traded range
52W low ₩14,850.0052W high ₩16,610.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

CELL BIOTECH CO ., LTD closed at ₩15,300.00, 27.6% below the consensus fair value of ₩21,123.16 drawn from 10 valuation models.

Financial DNA score 75/100 — Strong. P/E of 10.3x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₩19,277.18
+26.0%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=5.8%, r=10%, tg=3%, n=10yr
Graham Number
₩25,227.61
+64.9%
√(22.5 × EPS × BVPS)
EPS=1479, BVPS=19125
Graham Formula
₩39,518.88
+158.3%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=5.8%, FD=3.3%
P/E Fair Value
₩29,580.00
+93.3%
EPS × 20x (sector P/E)
EPS=1479, Sector P/E=20x
Peter Lynch (PEG)
₩8,533.83
-44.2%
EPS × Growth% (PEG = 1 is fair)
EPS=1479, g=5.8%
EV/EBITDA
₩14,894.73
-2.6%
(EBITDA × 12.9x − Net Debt) ÷ Shares
EBITDA=7.91B
Dividend Discount (DDM)
₩16,833.18
+10.0%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=673.2, r=10%, g=5.8%
Book Value (P/B)
₩8,680.85
-43.3%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=19125, ROE=7.7%, g=5.8%, r=10%
Reverse DCF
₩15,300.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: -1.8% | Historical: 5.8%
Margin of Safety
₩21,300.69
+39.2%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=28400.92, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.